MARKET

ONCSQ

ONCSQ

Oncosec Med Inc
EXMKT
0.0001
NaN%
Closed 09:30 04/24 EDT
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
19.58
52 WEEK LOW
0.0001
MARKET CAP
596.27
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ONCSQ last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at ONCSQ last week (0408-0412)?
Weekly Report · 04/15 11:49
Weekly Report: what happened at ONCSQ last week (0401-0405)?
Weekly Report · 04/08 11:55
Weekly Report: what happened at ONCSQ last week (0325-0329)?
Weekly Report · 04/01 11:52
Weekly Report: what happened at ONCSQ last week (0318-0322)?
Weekly Report · 03/25 11:56
Weekly Report: what happened at ONCSQ last week (0311-0315)?
Weekly Report · 03/18 11:53
Biotech bankruptcies hit a record despite sector’s recovery
Healthcare Biotech bankruptcies hit a record despite sector’s recovery. More biotech firms filed for Chapter 11 bankruptcy than any other year since 2010. In 2023, 18 biotech companies petitioned for court-mediated protection, compared to eight in 2022. The record number of biotech bankruptcies contrasts with the industry's recent gains.
Seeking Alpha · 03/14 18:54
Weekly Report: what happened at ONCSQ last week (0304-0308)?
Weekly Report · 03/11 11:49
More
About ONCSQ
OncoSec Medical Incorporated is a late-stage immuno-oncology company. The Company is focused on designing, developing and commercializing intra-tumoral DNA-based therapeutics delivered by electroporation (EP) to stimulate and augment anti-tumor immune responses for the treatment of cancers. Its technology platform, ImmunoPulse, is a drug-device therapeutic modality comprised of intertumoral EP delivery devices, such as the OncoSec Medical System (OMS) EP device. The OMS EP device is designed to deliver plasmid DNA-encoded drugs directly into a solid tumor and promote an immunological response against cancer. The OMS EP device adapts to treat different tumor types and consists of an electrical pulse generator, a reusable handle and disposable applicators. Its product candidate, TAVO is a drug-device combination. The drug consists of a plasmid construct called tavokinogene telseplasmid (TAVO) with plasmid DNA-encoded, IL-12, and is delivered into a tumor using its electroporation device.

Webull offers OncoSec Medical Inc stock information, including EXMKT: ONCSQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ONCSQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ONCSQ stock methods without spending real money on the virtual paper trading platform.